Program
MRNA-1469
A development code. Also written as “mRNA-1469”.
Its studies are led by Moderna.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Moderna | 22 open or running | phase 1since Jul 27, 2026 | Jul 27, 2026 | Sep 30, 2027phase 1 · NCT07737717 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 27, 2026First study: phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)First studyNCT07737717 · 84 enrolled · Canada
- Oct 30, 2026Phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)NCT07919197 · 224 planned · Uganda
Ahead
- Sep 30, 2027Primary completion: phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)NCT07737717
- Feb 1, 2028Primary completion: phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)NCT07919197
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07919197Ebola-Bundibugyo Virus Disease (Ebola-BDBV) · Uganda | 1 | Not yet recruiting | Feb 1, 2028 | 224 |
| NCT07737717Ebola-Bundibugyo Virus Disease (Ebola-BDBV) · Canada | 1 | Active, not recruiting | Sep 30, 2027 | 84 |
How it is read
Names in the registry
- “mRNA-1469”, 2 entries
Codes read as this program: MRNA1469.
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.